Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Toxicities”

421 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 421 results

Large-scale testing (Phase 3)Study completedNCT01276938
What this trial is testing

Exclusive Intraoperative Radiation Therapy for Breast Cancer

Who this might be right for
Breast NeoplasmsToxicity
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 40
Testing effectiveness (Phase 2)Ended earlyNCT01973608
What this trial is testing

MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma

Who this might be right for
Melanoma
EMD Serono 12
Not applicableStudy completedNCT01015326
What this trial is testing

Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors

Who this might be right for
Skin Toxicities
Northwestern University 32
Testing effectiveness (Phase 2)Ended earlyNCT00597597
What this trial is testing

Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Rush University Medical Center 11
Not applicableUnknownNCT04107168
What this trial is testing

Microbiome Immunotherapy Toxicity and Response Evaluation

Who this might be right for
MelanomaRenal CancerLung Cancer
CCTU- Cancer Theme 1,800
Testing effectiveness (Phase 2)WithdrawnNCT00397501
What this trial is testing

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more
OHSU Knight Cancer Institute
Not applicableStudy completedNCT01304251
What this trial is testing

Effects of Short-term Fasting on Tolerance to Chemotherapy

Who this might be right for
Breast Cancer
Leiden University Medical Center 13
Post-approval studies (Phase 4)Looking for participantsNCT07195344
What this trial is testing

Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.

Who this might be right for
Locally Advanced or Metastatic Breast Cancers
Institut Claudius Regaud 210
Testing effectiveness (Phase 2)UnknownNCT03638375
What this trial is testing

TIL and Anti-PD1 in Metastatic Melanoma

Who this might be right for
Toxicity, DrugAdverse Drug EventEffects of Immunotherapy
Leiden University 34
Not applicableUnknownNCT00122239
What this trial is testing

Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Who this might be right for
Breast CancerGliomaProstate Cancer+3 more
AHS Cancer Control Alberta 13
Testing effectiveness (Phase 2)Looking for participantsNCT06677944
What this trial is testing

Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Yonsei University 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04469075
What this trial is testing

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

Who this might be right for
GlioblastomaRecurrent GlioblastomaSkin Toxicity
Memorial Sloan Kettering Cancer Center 48
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Not applicableLooking for participantsNCT06627595
What this trial is testing

Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management

Who this might be right for
MelanomaImmunotoxicity
University Hospital, Montpellier 160
Testing effectiveness (Phase 2)Study completedNCT01763307
What this trial is testing

Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Hadassah Medical Organization 18
Testing effectiveness (Phase 2)Study completedNCT00332163
What this trial is testing

Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

Who this might be right for
Metastatic Colorectal CancerSkin RashSkin Toxicities+2 more
Amgen 95
Post-approval studies (Phase 4)UnknownNCT05302336
What this trial is testing

AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Toxicity
Second Affiliated Hospital, School of Medicine, Zhejiang University 402
Not applicableStudy completedNCT00524992
What this trial is testing

Evaluation of Albuminuria HIV-Infected Patients

Who this might be right for
HIV-Associated Focal Segmental GlomerulosclerosisHIV-Associated Collapsing GlomerulopathyProteinuria+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 252
Not applicableStudy completedNCT04133207
What this trial is testing

Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy

Who this might be right for
Breast Cancer Stage IV
Hellenic Cooperative Oncology Group 340
Not applicableStudy completedNCT00806507
What this trial is testing

Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 45
Load More Results